Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern

Using our strongly immunogenic SmT1 SARS-CoV-2 spike antigen platform, we developed antigens based on the Beta & Delta variants of concern (VOC). These antigens elicited higher neutralizing antibody activity to the corresponding variant than comparable vaccine formulations based on the original...

Descripción completa

Detalles Bibliográficos
Autores principales: Akache, Bassel, Renner, Tyler M., Stuible, Matthew, Rohani, Nazanin, Cepero-Donates, Yuneivy, Deschatelets, Lise, Dudani, Renu, Harrison, Blair A., Gervais, Christian, Hill, Jennifer J., Hemraz, Usha D., Lam, Edmond, Régnier, Sophie, Lenferink, Anne E. G., Durocher, Yves, McCluskie, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555707/
https://www.ncbi.nlm.nih.gov/pubmed/36224247
http://dx.doi.org/10.1038/s41541-022-00540-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555707/
https://www.ncbi.nlm.nih.gov/pubmed/36224247
http://dx.doi.org/10.1038/s41541-022-00540-7

Ejemplares similares